LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 32

Search options

  1. Article ; Online: A Remarkably Inaccurate Comparison of Glucose Management Technologies.

    Rhinehart, Andrew S

    Journal of diabetes science and technology

    2019  Volume 13, Issue 4, Page(s) 807–808

    MeSH term(s) Glucose ; Humans ; Hypoglycemia ; Insulin Infusion Systems
    Chemical Substances Glucose (IY9XDZ35W2)
    Language English
    Publishing date 2019-05-13
    Publishing country United States
    Document type Letter ; Comment
    ISSN 1932-2968
    ISSN (online) 1932-2968
    DOI 10.1177/1932296819841074
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Adding GLP-1 Receptor Agonist Therapy to Basal Insulin for Postprandial Glucose Control.

    Rhinehart, Andrew S

    Clinical diabetes : a publication of the American Diabetes Association

    2015  Volume 33, Issue 2, Page(s) 73–75

    Language English
    Publishing date 2015-04-20
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1025953-3
    ISSN 0891-8929
    ISSN 0891-8929
    DOI 10.2337/diaclin.33.2.73
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Early Real-World Performance of the MiniMed™ 780G Advanced Hybrid Closed-Loop System and Recommended Settings Use in the United States.

    Thrasher, James R / Arrieta, Arcelia / Niu, Fang / Cameron, Katherine R / Cordero, Toni L / Shin, John / Rhinehart, Andrew S / Vigersky, Robert A

    Diabetes technology & therapeutics

    2024  Volume 26, Issue S3, Page(s) 24–31

    Abstract: Background: ...

    Abstract Background:
    MeSH term(s) United States ; Humans ; Blood Glucose ; Blood Glucose Self-Monitoring ; Retrospective Studies ; Insulin/therapeutic use ; Insulin, Regular, Human ; Diabetes Mellitus, Type 1/drug therapy ; Glucose ; Hypoglycemic Agents/therapeutic use ; Insulin Infusion Systems
    Chemical Substances Blood Glucose ; Insulin ; Insulin, Regular, Human ; Glucose (IY9XDZ35W2) ; Hypoglycemic Agents
    Language English
    Publishing date 2024-02-20
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1452816-2
    ISSN 1557-8593 ; 1520-9156
    ISSN (online) 1557-8593
    ISSN 1520-9156
    DOI 10.1089/dia.2023.0453
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Inpatient glycemic control in 4 easy steps.

    Rhinehart, Andrew S

    Hospital practice (1995)

    2014  Volume 42, Issue 2, Page(s) 143–144

    MeSH term(s) Blood Glucose ; Humans ; Hyperglycemia/diagnosis ; Hyperglycemia/drug therapy ; Hypoglycemic Agents/administration & dosage ; Hypoglycemic Agents/therapeutic use ; Inpatients ; Insulin/administration & dosage ; Insulin/therapeutic use
    Chemical Substances Blood Glucose ; Hypoglycemic Agents ; Insulin
    Language English
    Publishing date 2014-04
    Publishing country England
    Document type Editorial
    ZDB-ID 2570453-9
    ISSN 2377-1003 ; 2154-8331 ; 8750-2836
    ISSN (online) 2377-1003
    ISSN 2154-8331 ; 8750-2836
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Integrating advances in insulin into clinical practice: Overview of current insulin formulations.

    Rhinehart, Andrew S

    The Journal of family practice

    2013  Volume 62, Issue 9 Suppl Insulin, Page(s) S4–8

    Abstract: Defects in both insulin secretion and function play a fundamental role in the pathophysiologic mechanisms underlying both type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM). As the most physiologic treatment option available, insulin ... ...

    Abstract Defects in both insulin secretion and function play a fundamental role in the pathophysiologic mechanisms underlying both type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM). As the most physiologic treatment option available, insulin plays a central role in the management of patients with T1DM and a growing role in the management of patients with T2DM, as is reflected in current treatment guidelines.
    MeSH term(s) Chemistry, Pharmaceutical ; Diabetes Mellitus, Type 1/drug therapy ; Diabetes Mellitus, Type 2/drug therapy ; Humans ; Hypoglycemic Agents/administration & dosage ; Hypoglycemic Agents/pharmacokinetics ; Hypoglycemic Agents/pharmacology ; Insulin Detemir ; Insulin Glargine ; Insulin, Isophane/administration & dosage ; Insulin, Isophane/pharmacokinetics ; Insulin, Isophane/pharmacology ; Insulin, Long-Acting/administration & dosage ; Insulin, Long-Acting/pharmacokinetics ; Insulin, Long-Acting/pharmacology ; Insulin, Short-Acting/administration & dosage ; Insulin, Short-Acting/pharmacokinetics ; Insulin, Short-Acting/pharmacology ; Insulins/administration & dosage ; Insulins/pharmacokinetics ; Insulins/pharmacology
    Chemical Substances Hypoglycemic Agents ; Insulin, Long-Acting ; Insulin, Short-Acting ; Insulins ; Insulin Glargine (2ZM8CX04RZ) ; Insulin Detemir (4FT78T86XV) ; Insulin, Isophane (53027-39-7)
    Language English
    Publishing date 2013-09
    Publishing country United States
    Document type Journal Article
    ZDB-ID 197883-4
    ISSN 1533-7294 ; 0094-3509
    ISSN (online) 1533-7294
    ISSN 0094-3509
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: A Peek Under the Hood: Explaining the MiniMed™ 780G Algorithm with Meal Detection Technology.

    Grosman, Benyamin / Roy, Anirban / Lintereur, Louis / Turksoy, Kamuran / Benedetti, Andrea / Cordero, Toni L / Vigersky, Robert A / McVean, Jennifer / Rhinehart, Andrew S / Cohen, Ohad

    Diabetes technology & therapeutics

    2024  Volume 26, Issue S3, Page(s) 17–23

    Abstract: The MiniMed™ 780G system (780G) received Conformité Européenne mark in June 2020 and was, recently, approved by the U.S. Food and Drug Administration (April 2023). Clinical trials and real-world analyses have demonstrated MiniMed™ 780G system safety and ... ...

    Abstract The MiniMed™ 780G system (780G) received Conformité Européenne mark in June 2020 and was, recently, approved by the U.S. Food and Drug Administration (April 2023). Clinical trials and real-world analyses have demonstrated MiniMed™ 780G system safety and effectiveness and that glycemic outcomes (i.e., time in range) improve with
    MeSH term(s) Humans ; Hypoglycemic Agents/therapeutic use ; Blood Glucose/analysis ; Diabetes Mellitus, Type 1/drug therapy ; Insulin/therapeutic use ; Insulin Infusion Systems ; Blood Glucose Self-Monitoring ; Algorithms
    Chemical Substances Hypoglycemic Agents ; Blood Glucose ; Insulin
    Language English
    Publishing date 2024-02-20
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1452816-2
    ISSN 1557-8593 ; 1520-9156
    ISSN (online) 1557-8593
    ISSN 1520-9156
    DOI 10.1089/dia.2023.0446
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Safety Event Outcomes and Glycemic Control with a Hybrid Closed-Loop System Used by Chinese Adolescents and Adults with Type 1 Diabetes Mellitus.

    Pei, Yu / Ke, Weijian / Lu, Jing / Lin, Yi / Zhang, Zhijian / Peng, Yongde / Bi, Yan / Li, Yanbing / Hou, Jue / Zhang, Xiaolu / Chen, Xiaoxiao / Treminio, Yuri / Lee, Scott W / Shin, John / Rhinehart, Andrew S / Vigersky, Robert A / Mu, Yiming

    Diabetes technology & therapeutics

    2023  Volume 25, Issue 10, Page(s) 718–725

    Abstract: Background: ...

    Abstract Background:
    Language English
    Publishing date 2023-09-05
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1452816-2
    ISSN 1557-8593 ; 1520-9156
    ISSN (online) 1557-8593
    ISSN 1520-9156
    DOI 10.1089/dia.2023.0234
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Cardiovascular Disease and Risk Management: Review of the American Diabetes Association Standards of Medical Care in Diabetes 2018.

    Chamberlain, James J / Johnson, Eric L / Leal, Sandra / Rhinehart, Andrew S / Shubrook, Jay H / Peterson, Lacie

    Annals of internal medicine

    2018  Volume 168, Issue 9, Page(s) 640–650

    Abstract: Description: The American Diabetes Association (ADA) annually updates its Standards of Medical Care in Diabetes to provide clinicians, patients, researchers, payers, and other interested parties with evidence-based recommendations for the diagnosis and ... ...

    Abstract Description: The American Diabetes Association (ADA) annually updates its Standards of Medical Care in Diabetes to provide clinicians, patients, researchers, payers, and other interested parties with evidence-based recommendations for the diagnosis and management of patients with diabetes.
    Methods: For the 2018 standards, the ADA Professional Practice Committee searched MEDLINE through November 2017 to add, clarify, or revise recommendations on the basis of new evidence. The committee rated the recommendations as A, B, or C depending on the quality of evidence or E for expert consensus or clinical experience. The standards were reviewed and approved by the Executive Committee of the ADA Board of Directors, which includes health care professionals, scientists, and laypersons. Feedback from the larger clinical community informed revisions.
    Recommendations: This synopsis focuses on guidance relating to cardiovascular disease and risk management in nonpregnant adults with diabetes. Recommendations address diagnosis and treatment of cardiovascular risk factors (hypertension and dyslipidemia), aspirin use, screening for and treatment of coronary heart disease, and lifestyle interventions.
    MeSH term(s) Adult ; Antihypertensive Agents/therapeutic use ; Aspirin/therapeutic use ; Blood Pressure Monitoring, Ambulatory ; Coronary Disease/diagnosis ; Coronary Disease/prevention & control ; Diabetes Mellitus/drug therapy ; Diabetes Mellitus/therapy ; Diabetic Angiopathies/prevention & control ; Dyslipidemias/diagnosis ; Dyslipidemias/prevention & control ; Healthy Lifestyle ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use ; Hypertension/diagnosis ; Hypertension/prevention & control ; Hypoglycemic Agents/therapeutic use ; Platelet Aggregation Inhibitors/therapeutic use ; Risk Factors ; Risk Management ; Standard of Care
    Chemical Substances Antihypertensive Agents ; Hydroxymethylglutaryl-CoA Reductase Inhibitors ; Hypoglycemic Agents ; Platelet Aggregation Inhibitors ; Aspirin (R16CO5Y76E)
    Language English
    Publishing date 2018-04-03
    Publishing country United States
    Document type Journal Article ; Practice Guideline
    ZDB-ID 336-0
    ISSN 1539-3704 ; 0003-4819
    ISSN (online) 1539-3704
    ISSN 0003-4819
    DOI 10.7326/M18-0222
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Diagnosis and Management of Diabetes: Synopsis of the 2016 American Diabetes Association Standards of Medical Care in Diabetes.

    Chamberlain, James J / Rhinehart, Andrew S / Shaefer, Charles F / Neuman, Annie

    Annals of internal medicine

    2016  Volume 164, Issue 8, Page(s) 542–552

    Abstract: Description: The American Diabetes Association (ADA) published the 2016 Standards of Medical Care in Diabetes (Standards) to provide clinicians, patients, researchers, payers, and other interested parties with the components of diabetes care, general ... ...

    Abstract Description: The American Diabetes Association (ADA) published the 2016 Standards of Medical Care in Diabetes (Standards) to provide clinicians, patients, researchers, payers, and other interested parties with the components of diabetes care, general treatment goals, and tools to evaluate the quality of care.
    Methods: The ADA Professional Practice Committee performed a systematic search on MEDLINE to revise or clarify recommendations based on new evidence. The committee assigns the recommendations a rating of A, B, or C, depending on the quality of evidence. The E rating for expert opinion is assigned to recommendations based on expert consensus or clinical experience. The Standards were reviewed and approved by the Executive Committee of the ADA Board of Directors, which includes health care professionals, scientists, and laypersons. Feedback from the larger clinical community was incorporated into the 2016 revision.
    Recommendations: The synopsis focuses on 8 key areas that are important to primary care providers. The recommendations highlight individualized care to manage the disease, prevent or delay complications, and improve outcomes.
    MeSH term(s) Adult ; Blood Glucose Self-Monitoring ; Cardiovascular Diseases/prevention & control ; Diabetes Complications/prevention & control ; Diabetes Mellitus/diagnosis ; Diabetes Mellitus/therapy ; Diabetes Mellitus, Type 1/therapy ; Diabetes Mellitus, Type 2/therapy ; Diabetic Angiopathies/prevention & control ; Diabetic Nephropathies/prevention & control ; Diabetic Neuropathies/prevention & control ; Glycated Hemoglobin A/metabolism ; Hospitalization ; Humans ; Hyperglycemia/therapy ; Hypoglycemia/therapy ; Hypoglycemic Agents/therapeutic use ; Insulin/therapeutic use ; Prediabetic State/diagnosis ; Risk Factors
    Chemical Substances Glycated Hemoglobin A ; Hypoglycemic Agents ; Insulin
    Language English
    Publishing date 2016-04-19
    Publishing country United States
    Document type Journal Article ; Practice Guideline
    ZDB-ID 336-0
    ISSN 1539-3704 ; 0003-4819
    ISSN (online) 1539-3704
    ISSN 0003-4819
    DOI 10.7326/M15-3016
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Glycemic Outcomes During Early Use of the MiniMed™ 780G Advanced Hybrid Closed-Loop System with Guardian™ 4 Sensor.

    Cordero, Toni L / Dai, Zheng / Arrieta, Arcelia / Niu, Fang / Vella, Melissa / Shin, John / Rhinehart, Andrew S / McVean, Jennifer / Lee, Scott W / Slover, Robert H / Forlenza, Gregory P / Shulman, Dorothy I / Pop-Busui, Rodica / Thrasher, James R / Kipnes, Mark S / Christiansen, Mark P / Buckingham, Bruce A / Pihoker, Catherine / Sherr, Jennifer L /
    Kaiserman, Kevin B / Vigersky, Robert A

    Diabetes technology & therapeutics

    2023  Volume 25, Issue 9, Page(s) 652–658

    Abstract: Background: ...

    Abstract Background:
    MeSH term(s) Adolescent ; Adult ; Child ; Humans ; Blood Glucose ; Blood Glucose Self-Monitoring ; Diabetes Mellitus, Type 1/drug therapy ; Glucose ; Glycated Hemoglobin ; Hypoglycemic Agents/therapeutic use ; Insulin/therapeutic use ; Insulin Infusion Systems
    Chemical Substances Blood Glucose ; Glucose (IY9XDZ35W2) ; Glycated Hemoglobin ; Hypoglycemic Agents ; Insulin
    Language English
    Publishing date 2023-06-16
    Publishing country United States
    Document type Clinical Trial ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1452816-2
    ISSN 1557-8593 ; 1520-9156
    ISSN (online) 1557-8593
    ISSN 1520-9156
    DOI 10.1089/dia.2023.0123
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top